Form 4 for CLBT Cellebrite DI Ltd.

Accepted 2026-08-13 18:17:07 ET · period of report 2026-08-11 · accession 0001628280-26-056875 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2026-08-13 18:17	2026-08-11	CLBT	Hogan Thomas E.	CEO, Dir	A - Grant	$0.00	+339.5K	930.3K	+57%	$0
	2026-08-13 18:17	2026-08-12	CLBT	Hogan Thomas E.	CEO, Dir	S - Sale	$15.39	-139.7K	790.5K	-15%	-$2.15M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Ordinary shares, par value NIS 0.00001	2026-08-11	A	A	339,484	$0.00	930,261	D	—	—	(F1) Represents ordinary shares of the Issuer delivered pursuant to the terms of performance share awards made to the reporting person on September 19, 2025. The performance-based vesting requirements applicable to such awards were satisfied on August 11, 2026, which represents the date on which the level of performance attained was certified.
2	Common	Ordinary shares, par value NIS 0.00001	2026-08-12	S	D	139,713	$15.39	790,548	D	—	—	(F2) Shares withheld from the vesting and distribution of performance share awards to satisfy the reporting person's tax obligations. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.06 to $15.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.